Ask an Expert
Bengaluru | 28 October 2025: In a move that reaffirms India’s growing leadership in global science, technology, and research, Thermo Fisher Scientific, the global leader in scientific solutions, has announced a ₹160 crore expansion of its R&D Centre of Excellence in Bengaluru.
The newly expanded 37,000 sq. ft. facility, equipped with state-of-the-art automation and analytical platforms, will focus on antibody design, development, and manufacturing, positioning Bengaluru as a critical innovation hub in the company’s global R&D network. The investment is expected to create over 100 new high-skilled jobs in Karnataka over the next few years.
Deepening Global-Local Integration in Life Sciences R&D
The expanded R&D Centre reflects Thermo Fisher’s commitment to harnessing India’s strong scientific talent and technological capabilities for advancing global healthcare and biopharma innovation.
The inauguration ceremony was graced by Sanjeev Kumar Gupta, CEO of the Karnataka Digital Economy Mission (KDEM), alongside senior representatives from KEONICS and the Karnataka Innovation & Technology Society (KITS), reaffirming the strategic partnership between global enterprises and the state’s innovation ecosystem.
“Bengaluru’s world-class digital infrastructure and deep pool of life sciences talent make it a natural base for high-end R&D and innovation. Investments like Thermo Fisher’s are a strong vote of confidence in Karnataka’s vision for a digital and research-driven economy,” noted Priyank Kharge, Karnataka’s Minister for Electronics, IT & BT, during the event.
Driving Next-Gen Therapeutics and Global Collaboration
With its expanded capabilities, Thermo Fisher’s Bengaluru centre is expected to play a pivotal role in driving AI-led antibody research, product innovation, and sustainable biomanufacturing. The centre will also serve as a global collaboration hub, supporting R&D programs across North America, Europe, and Asia.
By integrating advanced automation tools and digital platforms, the facility aims to accelerate the discovery-to-delivery cycle, enabling faster development of life-saving therapeutics while ensuring precision and scalability.
A Testament to India’s Rising R&D Leadership
Thermo Fisher’s continued investment in Bengaluru adds to a growing list of global companies expanding their R&D and GCC operations in India. From biopharma and healthcare to technology and engineering, enterprises are increasingly transitioning India’s centers from support units to innovation engines. For Karnataka, the development strengthens its reputation as a preferred global destination for high-value research, digital transformation, and life sciences manufacturing.
SSF Global View
Thermo Fisher’s Bengaluru expansion exemplifies how global leaders are anchoring their innovation agendas in India, transforming the country’s GCC landscape into a hub of scientific excellence and technological foresight, thereby reimagining the Value, Vision, and Velocity of Global India.
